These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8438311

  • 1. Intrathymic injection of donor antigen-presenting cells prolongs heart graft survival.
    Krokos NV, Brons IG, Sriwatanawongsa V, Makisalo H, Katami M, Davies HS, Calne RY.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):303-4. PubMed ID: 8438311
    [No Abstract] [Full Text] [Related]

  • 2. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T, Imanishi M, Hara Y, Tahara H, Kanda H, Kurita T.
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract] [Full Text] [Related]

  • 3. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
    Goldstein C, Reiss GR, Mohiuddin M, Shen Z, Yokoyama H, DiSesa VJ.
    J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
    [Abstract] [Full Text] [Related]

  • 4. Viable antigen-presenting cells are required for induction of intrathymic tolerance.
    Nakafusa Y, Goss JA, Flye MW.
    Transplant Proc; 1994 Apr; 26(2):845-6. PubMed ID: 8171684
    [No Abstract] [Full Text] [Related]

  • 5. Donor-specific cardiac allograft tolerance without immunosuppression after intrathymic injection of donor alloantigen.
    Goss JA, Nakafusa Y, Flye MW.
    Transplant Proc; 1992 Dec; 24(6):2879-80. PubMed ID: 1465981
    [No Abstract] [Full Text] [Related]

  • 6. Intrathymic injection of donor splenocytes plus systemic antilymphocyte serum or antilymphocyte serum alone prolongs cardiac allograft survival and inhibits graft arteriosclerosis in the Lewis-to-F344 chronic rejection model.
    Shin YT, Adams DH, Wyner LR, Akalin E, Sayegh MH, Karnovsky MJ.
    Transplant Proc; 1995 Jun; 27(3):2112-4. PubMed ID: 7792902
    [No Abstract] [Full Text] [Related]

  • 7. Prolonged survival of rat cardiac allografts after intrathymic inoculation of donor thymocytes.
    Odorico JS, Barker CF, Markmann JF, Posselt AM, Naji A.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):295-6. PubMed ID: 8438306
    [No Abstract] [Full Text] [Related]

  • 8. Importance of the presence of antigen for induction of transplantation tolerance.
    Olausson M, Mjörnstedt L, Wramner L, Söderström T, Brynger H.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):454-6. PubMed ID: 3274804
    [No Abstract] [Full Text] [Related]

  • 9. Tolerance of rat cardiac allografts does not require donor-type "passenger" antigen presenting cells.
    Popma SH, Krasinskas AM, McLean AD, Eiref SD, Moore JS, Hruban RH, Rosengard BR.
    Transplant Proc; 1999 Feb; 31(1-2):840-1. PubMed ID: 10083365
    [No Abstract] [Full Text] [Related]

  • 10. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR, Randolph MA, Lee WP.
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous transplantation and intrathymic tolerance induction. A method with clinical potential.
    Klatter FA, Raué HP, Bartels HL, Pater JM, Groen H, Nieuwenhuis P, Kampinga J.
    Transplantation; 1995 Dec 15; 60(11):1208-10. PubMed ID: 8525511
    [Abstract] [Full Text] [Related]

  • 12. Tolerance induction to cardiac allografts by sequential intrathymic inoculation of disparate alloantigens.
    Shimomura K, Hardy MA, Oluwole SF.
    Transplant Proc; 1996 Jun 15; 28(3):1283-4. PubMed ID: 8658661
    [No Abstract] [Full Text] [Related]

  • 13. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z, Mohiuddin M, DiSesa VJ.
    Ann Thorac Surg; 1995 Dec 15; 60(6):1683-5. PubMed ID: 8787463
    [Abstract] [Full Text] [Related]

  • 14. Intrathymic tolerance induction is based on suppressor cells.
    Kampinga J, Klatter F, Bartels H, Pater J, Nieuwenhuis P, Roser B, Groen H.
    Transplant Proc; 1994 Apr 15; 26(2):725-6. PubMed ID: 8171626
    [No Abstract] [Full Text] [Related]

  • 15. Is donor-specific blood transfusion effective for strong minor histocompatibility antigen barriers?
    Hara MH, Suzuki H, Shibata K, Tanigawa M, Sekiya R, Matsuzaki Y, Onitsuka T, Koga Y, Yamashita A, Miyamoto M, Suzuki S, Amemiya H, Kimura H.
    Transplant Proc; 1996 Jun 15; 28(3):1268-9. PubMed ID: 8658654
    [No Abstract] [Full Text] [Related]

  • 16. Tolerance in murine cardiac allografts by concurrent infusion of viable donor antigen-bearing cells.
    Smith XG, Chen ZK, Brons IG, Frick TW.
    Transplant Proc; 1999 Jun 15; 31(1-2):133-4. PubMed ID: 10083044
    [No Abstract] [Full Text] [Related]

  • 17. Cloned veto cells as immunoregulators.
    Takeda Y, Yanagie H, Maki T.
    Transplant Proc; 1993 Aug 15; 25(4):2743-4. PubMed ID: 8356732
    [No Abstract] [Full Text] [Related]

  • 18. Infectious tolerance develops after intrathymic alloantigen-induced acceptance of rat heart allografts can be adoptively transferred.
    Takayashiki T, Asakura H, Ku G, Kataoka M, Flye MW.
    Surgery; 2005 Aug 15; 138(2):254-60. PubMed ID: 16153434
    [Abstract] [Full Text] [Related]

  • 19. Effect of intrathymic injection of donor splenocytes on rat small bowel allograft survival.
    Karim MS, Webster GA, Wood RF, Pockley AG.
    Transplant Proc; 1994 Jun 15; 26(3):1583-4. PubMed ID: 8030047
    [No Abstract] [Full Text] [Related]

  • 20. Portal tolerance in rats: effect of donor cell treatment and timing of administration.
    Tanigawa T, Monden M, Nagano H, Hasuike Y, Gotoh M, Fukuzaki T, Ota H, Yoshida T, Mori T.
    Transplant Proc; 1994 Aug 15; 26(4):1870-1. PubMed ID: 8066608
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.